Social Anxiety DisorderNCT07099521
The Effects of HD-tDCS on Cognitive Bias Among Individuals With Social Anxiety Symptoms
A study testing Active High-definition transcranial direct current stimulation in people with Social Anxiety Disorder, run by South China Normal University at 1 site in China.
Trial summary
To examine the offline effects of high-definition tDCS (HD-tDCS) on attention, interpretation and memory biases in youth with social anxiety. Read more about this study
- Who is it for?
- Ages 18 to 24 years
- Conditions the study is for
- Social Anxiety Disorder
- What is being tested?
- Active High-definition transcranial direct current stimulation
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 74 participants
- Where
- 1 siteChina
- Study dates
- 15 May 2024to 24 Dec 2024
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 24 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- 18 -24 years old
- No history of major organic brain diseases or mental disorders, and currently not taking hormone or mental disorder drugs, with no drug or alcohol dependence;
- No experience of transcranial direct current stimulation (tDCS) or transcranial magnetic stimulation (TMS) in the past six months;
- Participants are willing to participate and fill out the informed consent form;
- The score of the Patient Health Questionnaire (PHQ-9) is less than 5 points;
- The score of the Liebowitz Social Anxiety Scale (LSAS) is greater than or equal to 55 points
Who cannot join
- any psychiatric disorders;
- current or past diseases or injuries related to the brain;
- medical pumps, pacemakers and cochlear implants in the body;
- current pharmacological or mental treatments;
- tDCS or TMS experiences over past year were also excluded.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effects of High-definition Transcranial Direct Current Stimulation on Cognitive Bias Among Individuals With Social Anxiety Symptoms
To examine the offline effects of high-definition tDCS (HD-tDCS) on attention, interpretation and memory biases in youth with social anxiety.
Read the detailed description
In current study, we adopted a comparative intervention study with randomized controlled in which we delivered multiple courses of offline anodal HD-tDCS over the left DLPFC. The aim of this study was to explore the offline impact of HD-tDCS on cognitive bias (including attention, interpretation and memory bias) among youth with social anxiety symptoms. In addition, the researchers sought to further investigate the impact of tDCS stimulation on social anxiety. We hypothesized that anodal tDCS would activates the left DLPFC to facilitate cognitive control of threat-related information among youth with social anxiety, thereby reducing threat attention, interpretation and memory bias, and even improving social anxiety symptoms.
- Conditions
- Social Anxiety Disorder
- Being tested
- Active High-definition transcranial direct current stimulation, Sham high-definition transcranial direct current stimulation
- Medical subject headings
- Phobia, Social
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Active High-definition transcranial direct current stimulationDevice
Participants completed 10 sessions of anodal HD-tDCS stimulation over 5 consecutive days (two 20-minute sessions per day, with a 3-hour interval between sessions). Stimulation was delivered using an HD-tES device (Soterix Medical, Inc, Woodbridge, NJ, USA), targeting the left dorsolateral prefrontal context (DLPFC). In the active HD-tDCS condition, current was ramped up to 2mA over 30 seconds, maintained for 20 minutes, then ramped down to 0mA at the end.
Sham high-definition transcranial direct current stimulationDevice
Participants completed 10 sessions of sham HD-tDCS stimulation over 5 consecutive days (two 20-minute sessions per day, with a 3-hour interval between sessions). Stimulation was delivered using an HD-tES device (Soterix Medical, Inc, Woodbridge, NJ, USA), targeting the left dorsolateral prefrontal context (DLPFC). In the sham condition, the current was ramped up to 2mA within the first and last 30 seconds to mimic the sensation of stimulation, but then ramped down, with no current maintained at other times.
| Study group | Role | What they receive |
|---|---|---|
| tDCS group | Active comparator | Participants underwent 10 sessions of anodal (2mA, 20 minutes) HD-tDCS over 5 days targeting the left dorsolateral prefrontal cortex (DLPFC). Receives: Device: Active High-definition transcranial direct current stimulation |
| Sham group | Sham comparator | Participants underwent 10 sessions of sham HD-tDCS over 5 days targeting the left dorsolateral prefrontal cortex (DLPFC). Receives: Device: Sham high-definition transcranial direct current stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Trial-level Bias Score (Negative)
Assessment: Dot probe task;Indicator of Attention Avoidance. Dot probe task is a common experimental paradigm for measuring attention bias. After appearance of a fixed cross in the center of the computer screen, a pair of faces appear side by side. Then, a probe appears on the location previously occupied by one of the two faces. Participants were asked to response the location of the probe as quickly as possible and press the appropriate keys to answer.
This study used the trail-level bias score (TL-BS) as a measure of the main outcomes of this task. TL-BS is an indicator of reaction time (RT), calculated by subtracting contiguous pairs of congruent trials (probe and emotional face appeared on the same location of the screen) from incongruent trials (probe and emotional face appeared on the opposite location of the screen).Negative scores represent avoidance of these stimuli. TL-BSnegative indicates the average value of TL-BSs <0ms
Measured: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5).
Endorsement Rates of Negative Interpretations
Assessment: Word-sentence association paradigm; Indicator of Negative interpretation bias.
Word sentence association paradigm (WSAP) was used to assess the interpretation bias in youth with social anxiety. Following the appearance of a fixed cross (500ms), an ambiguous sentence describing the social situation would be presented in the center of the screen (2000ms). Then, a word would appear at random for 500ms: the word might imply a threatening interpretation (e.g., "boring" or "rejection"), or imply a benign one (e.g., "captivating" or "accepted"). Participants were asked to decide whether the word was related to the ambiguous sentence ("F" for relevant and "J" for irrelevant).
This study calculated the proportion of threaten interpretations that participants endorsed as being related to the sentence (Endorsement rates of negative interpretations), which was prescribed as the primary result of interpretation bias.
Measured: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Recognition Accuracy for Negative Words
Assessments: recognition task; Indicator of Negative Memory bias. This study used free recall and recognition task to assess memory bias by the number of positive/negative words remembered. First, in the "encoding phase", after a short time for a fixed cross, words were presented randomly in turn . Participants were asked to read these words aloud and answer coding questions.After this phase, there was a 3-minute distraction task, during which participants were guided through 40 calculation problems. They were then given 2 minutes to freely recall the words that had appeared before, regardless of the order of the words. Next, they completed a recognition task. Recognition Accuracy was calculated as: (number of correctly recognized negative words) ÷ (total number of negative words presented).
Measured: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Secondary outcomes (8)
Peak Trial-level Bias Score (Negative)
Assessments: Dot-probe task; Indicator of Attention Avoidance. Dot probe task is a common experimental paradigm for measuring attention bias. After appearance of a fixed cross in the center of the computer screen, a pair of faces appear side by side. Then, a probe appears on the location previously occupied by one of the two faces. Participants were asked to response the location of the probe as quickly as possible and press the appropriate keys to answer.
This study used the trail-level bias score (TL-BS) as a measure of the main outcomes of this task. TL-BS is an indicator of reaction time (RT), calculated by subtracting contiguous pairs of congruent trials (probe and emotional face appeared on the same location of the screen) from incongruent trials (probe and emotional face appeared on the opposite location of the screen).Negative scores represent avoidance of these stimuli. Peak TL-BSnegative indicates the minimum TL-BS value.
Measured: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Bias Score
Assessments: Word-sentence association paradigm; Indicator of Negative interpretation bias.
Word sentence association paradigm (WSAP) was used to assess the interpretation bias in youth with social anxiety. Following the appearance of a fixed cross (500ms), an ambiguous sentence describing the social situation would be presented in the center of the screen (2000ms). Then, a word would appear at random for 500ms: the word might imply a threatening interpretation (e.g., "boring" or "rejection"), or imply a benign one (e.g., "captivating" or "accepted"). Participants were asked to decide whether the word was related to the ambiguous sentence ("F" for relevant and "J" for irrelevant).
This study recorded the response time and calculated the bias index (BI): threat BI = response times (reject threat - endorse threat) and benign BI = response times (endorse benign - reject benign).
Measured: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Recall Accuracy for Negative Words
Assessments: free recall task; Indicator of negative memory bias. This study used free recall and recognition task to assess memory bias by the number of positive/negative words remembered. First, in the "encoding phase", after a short time for a fixed cross, words were presented randomly in turn . Participants were asked to read these words aloud and answer coding questions.After this phase, there was a 3-minute distraction task, during which participants were guided through 40 calculation problems. They were then given 2 minutes to freely recall the words that had appeared before, regardless of the order of the words. Next, they completed a recognition task. Recall Accuracy was calculated as: (number of correctly recall negative words) ÷ (total number of negative words presented).
Measured: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Social Anxiety Symptoms
Assessments: the Liebowitz Social Anxiety Scale. The Liebowitz Social Anxiety Scale (LSAS) was used to identify participants with social anxiety and to assess changes in social anxiety symptoms before and after the tDCS intervention. The scale contains 24 items, each of which assesses two aspects of fear and avoidance, using a 4-point Likert scale ("0" means "never" and "3" means "severe"), for a total of 48 items. A higher score indicated more severe social anxiety. The score ranges from 0 to 144. The total score would be categorized into 5 severity levels: 0-54 (normal), 55-64 (moderate), 65-79 (marked), 80-94 (severe), and ≥95 (very severe). In this study, participants scoring between 55 and 95 were included. The LSAS has demonstrated good internal consistency across three assessments (Cronbach's alpha = 0.87-0.90), and acceptable test-retest consistency (r = 0.47-0.79, p < 0.001).
Measured: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Trait Anxiety
Assessments: the Spielberger Inventory - Trait (STAI-T). Trait anxiety was assessed using the Spielberger Trait Anxiety Inventory - Trait (STAI-T), which included 20 items rated on a 4-point scale, ranging from 20 to 80 (1 = "not at all" to 4 = "very much"). A higher score indicates severe trait anxiety symptoms. In this study, the STAI-T demonstrated good internal and test-retest reliability (Cronbach's alpha = 0.80-0.86; r = 0.69-0.79, p < 0.001).
Measured: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Negative Cognitive Bias (Attention Bias)
Assessments: the Negative cognitive processing bias questionnaire; Indicator of self-report attention bias.
Participants completed the Negative cognitive processing bias questionnaire (NCPBQ). The NCPBQ included 17 items divided into three subscales, along with three lie-detection items. Among it, the attention bias subscale includes 5 items (E.g., My attention is easily drawn to the tragic images on TV and is difficult to shift). Items were rated on a 5-point Likert scale from 1 ("disagree completely") to 5 ("agree completely"), with higher score indicating more severe cognitive bias. The score of attention bias subscale ranges from 5 to 25.
Measured: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Negative Cognitive Bias (Interpretation Bias)
Assessments: the Negative cognitive processing bias questionnaire; Indicator of self-report interpretation bias.
Participants completed the Negative cognitive processing bias questionnaire (NCPBQ). The NCPBQ included 17 items divided into three subscales, along with three lie-detection items. Among it, the interpretation bias subscale includes 5 items (E.g., If a new teacher is hard on me, I think it is because he sees me in a bad light and wants to get me in trouble). Items were rated on a 5-point Likert scale from 1 ("disagree completely") to 5 ("agree completely"), with higher score indicating more severe cognitive bias . The score of interpretation bias subscale ranges from 5 to 25.
Measured: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Negative Cognitive Bias (Memory Bias)
Assessments: the Negative cognitive processing bias questionnaire; Indicator of self-report memory bias.
Participants completed the Negative cognitive processing bias questionnaire (NCPBQ). The NCPBQ included 17 items divided into three subscales, along with three lie-detection items. Among it, the memory bias subscale includes 4 items (E.g., I can easily remember the negative comments people make about me). Items were rated on a 5-point Likert scale from 1 ("disagree completely") to 5 ("agree completely"), with higher score indicating more severe cognitive bias . The score of memory bias subscale ranges from 5 to 20.
Measured: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Aug 2025
- Study start15 May 2024
- Primary completion24 Nov 2024
- Study completion24 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Social Anxiety DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 74 participants (actual)
Sponsor and investigators
- Lead sponsor
- South China Normal University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yi Yu, South China Normal University
- Investigators
- Yi Yu, Principal investigator, South China Normal UniversityYuanyuan Wang, Study chair, South China Normal University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07099521
- Sponsor's protocol ID
- SCNU-PSY-2024-185
- Status last verified
- Nov 2025
- First submitted
- 25 Jul 2025
- Last updated
- 10 Dec 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The original data will not be made public before the paper is published
Study at a glance
From the registry record, last updated by the sponsor on 10 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of High-definition Transcranial Direct Current Stimulation on Cognitive Bias Among Individuals With Social Anxiety Symptoms
- ClinicalTrials.gov ID
- NCT07099521
- Acronym / sponsor ID
- SCNU-PSY-2024-185
- Conditions
- Social Anxiety Disorder
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 74 participants (actual)
- Lead sponsor
- South China Normal UniversityUniversity, hospital or other
- Study start
- 15 May 2024 (actual)
- Primary completion
- 24 Nov 2024 (actual)
- Study completion
- 24 Dec 2024 (actual)
- First posted
- 1 Aug 2025 (actual)
- Results
- Posted 10 Dec 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To examine the offline effects of high-definition tDCS (HD-tDCS) on attention, interpretation and memory biases in youth with social anxiety.
Detailed description
In current study, we adopted a comparative intervention study with randomized controlled in which we delivered multiple courses of offline anodal HD-tDCS over the left DLPFC. The aim of this study was to explore the offline impact of HD-tDCS on cognitive bias (including attention, interpretation and memory bias) among youth with social anxiety symptoms. In addition, the researchers sought to further investigate the impact of tDCS stimulation on social anxiety. We hypothesized that anodal tDCS would activates the left DLPFC to facilitate cognitive control of threat-related information among youth with social anxiety, thereby reducing threat attention, interpretation and memory bias, and even improving social anxiety symptoms.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| tDCS group | Active comparator | Device: Active High-definition transcranial direct current stimulationParticipants underwent 10 sessions of anodal (2mA, 20 minutes) HD-tDCS over 5 days targeting the left dorsolateral prefrontal cortex (DLPFC). |
| Sham group | Sham comparator | Device: Sham high-definition transcranial direct current stimulationParticipants underwent 10 sessions of sham HD-tDCS over 5 days targeting the left dorsolateral prefrontal cortex (DLPFC). |
Who may qualify
- Ages
- 18 to 24 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- 18 -24 years old
- No history of major organic brain diseases or mental disorders, and currently not taking hormone or mental disorder drugs, with no drug or alcohol dependence;
- No experience of transcranial direct current stimulation (tDCS) or transcranial magnetic stimulation (TMS) in the past six months;
- Participants are willing to participate and fill out the informed consent form;
- The score of the Patient Health Questionnaire (PHQ-9) is less than 5 points;
Key exclusion criteria (5 listed)
- any psychiatric disorders;
- current or past diseases or injuries related to the brain;
- medical pumps, pacemakers and cochlear implants in the body;
- current pharmacological or mental treatments;
- tDCS or TMS experiences over past year were also excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Active High-definition transcranial direct current stimulationParticipants completed 10 sessions of anodal HD-tDCS stimulation over 5 consecutive days (two 20-minute sessions per day, with a 3-hour interval between sessions). Stimulation was delivered using an HD-tES device (Soterix Medical, Inc, Woodbridge, NJ, USA), targeting the left dorsolateral prefrontal context (DLPFC). In the active HD-tDCS condition, current was ramped up to 2mA over 30 seconds, maintained for 20 minutes, then ramped down to 0mA at the end. | Device | tDCS group |
| Sham high-definition transcranial direct current stimulationParticipants completed 10 sessions of sham HD-tDCS stimulation over 5 consecutive days (two 20-minute sessions per day, with a 3-hour interval between sessions). Stimulation was delivered using an HD-tES device (Soterix Medical, Inc, Woodbridge, NJ, USA), targeting the left dorsolateral prefrontal context (DLPFC). In the sham condition, the current was ramped up to 2mA within the first and last 30 seconds to mimic the sensation of stimulation, but then ramped down, with no current maintained at other times. | Device | Sham group |
Primary outcome
Trial-level Bias Score (Negative)
Time frame: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5).
Assessment: Dot probe task;Indicator of Attention Avoidance. Dot probe task is a common experimental paradigm for measuring attention bias. After appearance of a fixed cross in the center of the computer screen, a pair of faces appear side by side. Then, a probe appears on the location previously occupied by one of the two faces. Participants were asked to response the location of the probe as quickly as possible and press the appropriate keys to answer. This study used the trail-level bias score (TL-BS) as a measure of the main outcomes of this task. TL-BS is an indicator of reaction time (RT), calculated by subtracting contiguous pairs of congruent trials (probe and emotional face appeared on the same location of the screen) from incongruent trials (probe and emotional face appeared on the opposite location of the screen).Negative scores represent avoidance of these stimuli. TL-BSnegative indicates the average value of TL-BSs <0ms
Endorsement Rates of Negative Interpretations
Time frame: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Assessment: Word-sentence association paradigm; Indicator of Negative interpretation bias. Word sentence association paradigm (WSAP) was used to assess the interpretation bias in youth with social anxiety. Following the appearance of a fixed cross (500ms), an ambiguous sentence describing the social situation would be presented in the center of the screen (2000ms). Then, a word would appear at random for 500ms: the word might imply a threatening interpretation (e.g., "boring" or "rejection"), or imply a benign one (e.g., "captivating" or "accepted"). Participants were asked to decide whether the word was related to the ambiguous sentence ("F" for relevant and "J" for irrelevant). This study calculated the proportion of threaten interpretations that participants endorsed as being related to the sentence (Endorsement rates of negative interpretations), which was prescribed as the primary result of interpretation bias.
Recognition Accuracy for Negative Words
Time frame: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Assessments: recognition task; Indicator of Negative Memory bias. This study used free recall and recognition task to assess memory bias by the number of positive/negative words remembered. First, in the "encoding phase", after a short time for a fixed cross, words were presented randomly in turn . Participants were asked to read these words aloud and answer coding questions.After this phase, there was a 3-minute distraction task, during which participants were guided through 40 calculation problems. They were then given 2 minutes to freely recall the words that had appeared before, regardless of the order of the words. Next, they completed a recognition task. Recognition Accuracy was calculated as: (number of correctly recognized negative words) ÷ (total number of negative words presented).
8 secondary outcomes
Peak Trial-level Bias Score (Negative)
Time frame: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Bias Score
Time frame: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Recall Accuracy for Negative Words
Time frame: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5)
Social Anxiety Symptoms
Time frame: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Trait Anxiety
Time frame: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Negative Cognitive Bias (Attention Bias)
Time frame: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Negative Cognitive Bias (Interpretation Bias)
Time frame: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Negative Cognitive Bias (Memory Bias)
Time frame: Self-report questionnaires were administered at baseline (Day 1), immediately after the last stimulation session (Day 5), and at a 4-week follow-up (Day 30).
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Dec 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No. The original data will not be made public before the paper is published
Related trials for Social Anxiety Disorder
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Bonding Before Birth: A mHealth Intervention for First-time Expectant Couples
Anxiety, Pregnancy
Recruiting
Comprehensive Assessment of Rehabilitation Experience Using the SAFE Scale
Caregiver Anxiety, Acquired Brain Injury
Not yet recruiting
Online Study on the Impact of a Self-Help Tool for Social Anxiety
Social Anxiety
Active, not recruiting
Targeting Social Function in Anxiety and Eating Disorders
Eating Disorders, Anorexia Nervosa
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yi Yu principal investigator
South China Normal University
Yuanyuan Wang study chair
South China Normal University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Active High-definition transcranial direct current stimulation in people with Social Anxiety Disorder, run by South China Normal University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 10 Dec 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Trial-level Bias Score (Negative) (time frame: This task was administered at baseline (Day 1) and immediately after the last stimulation session (Day 5).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2025.